| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 53,290 | 46,507 | 48,876 | 53,952 | | Cost of Revenue | 25,733 | 22,793 | 23,858 | 26,201 | | | Gross Profit | 27,557 | 23,714 | 25,018 | 27,751 | | | Operating Expenses | | Research Development | 13,353 | 11,976 | 12,104 | 11,031 | | Selling General and Administrative | 13,053 | 11,434 | 11,131 | 12,417 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 571 | 794 | 479 | 389 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 580 | (490) | 1,304 | 3,914 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 455 | 149 | 135 | (410) | | Earnings Before Interest And Taxes | 1,035 | (341) | 1,439 | 3,504 | | Interest Expense |
-
|
-
|
-
| 57 | | Income Before Tax | 1,035 | (341) | 1,439 | 3,447 | | Income Tax Expense | 105 | (12) | 244 | (1,524) | | Minority Interest |
-
| 197 | (197) |
-
| | | | Net Income From Continuing Ops | 657 | (376) | 998 | 4,777 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 657 | (376) | 998 | 4,777 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $657 | ($376) | $998 | $4,777 |
|
0.02% Nasdaq 0.00%
Income Statement
